LOPINAVIR — all Canadian products
3 DINs
2 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is LOPINAVIR, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02243644 | KALETRA | ABBVIE CORPORATION | Solution | Oral | LOPINAVIR 400 MG; RITONAVIR 100 MG | Marketed | |
| 02312301 | KALETRA | ABBVIE CORPORATION | Tablet | Oral | LOPINAVIR 100 MG; RITONAVIR 25 MG | Marketed | |
| 02243643 | KALETRA | ABBVIE CORPORATION | Capsule | Oral | LOPINAVIR 133.3 MG; RITONAVIR 33.3 MG | Cancelled Post Market |
Browse other molecules: